Carney's triad

Carney's triad

Carney's Triad is a rare medical condition characterized by the occurrence of three specific types of tumors: gastrointestinal stromal tumors (GISTs), pulmonary chondromas, and extra-adrenal paragangliomas. It was first described by J. Aidan Carney in 1977, and its etiology remains largely unknown, with both genetic and environmental factors being investigated.

Overview

Carney's Triad is considered a non-hereditary condition, predominantly affecting young females. The diagnosis is challenging due to the rarity of the condition, the age of onset, and the variety of symptoms that can arise depending on the location and size of the tumors. The triad does not always present simultaneously, and in some cases, only two of the three tumors are identified, a condition referred to as Carney's dyad.

Clinical Features

The clinical presentation of Carney's Triad can vary significantly among patients, largely depending on the size, location, and number of tumors. Common symptoms may include gastrointestinal bleeding or discomfort, respiratory difficulties, and symptoms related to catecholamine secretion by paragangliomas such as hypertension.

Gastrointestinal Stromal Tumors (GISTs)

GISTs are the most common component of Carney's Triad and are found in the stomach or small intestine. They may cause abdominal pain, gastrointestinal bleeding, or be asymptomatic and discovered incidentally.

Pulmonary Chondromas

Pulmonary chondromas are benign tumors of the lung. Patients may be asymptomatic or present with respiratory symptoms such as cough or chest pain.

Extra-adrenal Paragangliomas

Extra-adrenal paragangliomas are tumors that arise from the paraganglionic system outside the adrenal glands, often leading to symptoms related to the overproduction of catecholamines, including hypertension, sweating, and palpitations.

Diagnosis

The diagnosis of Carney's Triad is primarily clinical, supported by imaging studies such as CT scans or MRI, and confirmed by histopathological examination of the tumors. Due to its rarity, Carney's Triad is often diagnosed retrospectively after two or more of the tumors have been identified.

Treatment

Treatment of Carney's Triad is tailored to the individual patient and depends on the type, size, and location of the tumors. Surgical resection is the mainstay of treatment for GISTs and can be curative. Pulmonary chondromas are often monitored unless they cause significant symptoms or complications. Treatment of extra-adrenal paragangliomas may involve surgery, radiation therapy, or pharmacotherapy to manage symptoms of catecholamine excess.

Prognosis

The prognosis for patients with Carney's Triad varies. While the tumors associated with the condition are generally slow-growing, the potential for malignancy, particularly with GISTs and paragangliomas, necessitates careful long-term monitoring and management.

Epidemiology

Carney's Triad is extremely rare, with only a few hundred cases reported in the medical literature. It has a predilection for young females, although the reasons for this gender disparity are not well understood.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian